| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Lucitanib |
➤ Sign Up |
Spiro substituted compounds as angiogenesis inhibitors |
Advenchen Laboratories, LLC (Northridge, CA) |
➤ Sign Up |
| Lucitanib |
➤ Sign Up |
Spiro substituted compounds as angiogenesis inhibitors |
Advenchen Laboratories, LLC (Moorpark, CA) |
➤ Sign Up |
| Lucitanib |
➤ Sign Up |
Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof |
EOS Ethical Oncology S.p.A. Abbreviated Form EOS S.p.A. (Milan, IT) |
➤ Sign Up |
| Lucitanib |
➤ Sign Up |
Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof |
Clovis Oncology Italy S.R.L. (Milan, IT) |
➤ Sign Up |
| Lucitanib |
➤ Sign Up |
Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof |
CLOVIS ONCOLOGY ITALY S.R.L. (Milan, IT) |
➤ Sign Up |
| Lucitanib |
➤ Sign Up |
Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and its crystalline |
Advenchen Pharmaceuticals, LLC (Moorpark, CA) |
➤ Sign Up |
| Lucitanib |
➤ Sign Up |
Rho kinase inhibitors |
Kadmon Corporation, LLC (New York, NY) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
